Hybrid SPECT-CT with 99mTc-labeled red blood cell in a case of blue rubber bleb nevus syndrome: added value over planar scintigraphy
PDF
Cite
Share
Request
Nuclear Medicine - Case Report
P: 41-43
January 2013

Hybrid SPECT-CT with 99mTc-labeled red blood cell in a case of blue rubber bleb nevus syndrome: added value over planar scintigraphy

Diagn Interv Radiol 2013;19(1):41-43
1. Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
No information available.
No information available
Received Date: 08.03.2012
Accepted Date: 09.06.2012
PDF
Cite
Share
Request

ABSTRACT

Blue rubber bleb nevus syndrome (BRBNS) is a rare vascular anomaly syndrome consisting of multifocal venous malformations most commonly involving the skin, soft tissues, and gastrointestinal tract. The gastrointestinal lesions of BRBNS are the most clinically relevant malformations and carry a significant potential for serious bleeding. William Bennet Bean first coined the term “BRBNS” in 1958, and only 200 cases have been described since then (1). A few reports have described the use of 99mechnetium (99mTc)-labeled red blood cell (RBC) planar scintigraphy in BRBNS patients to localize the site of bleeding (2–5). To the best of our knowledge, however, the role of single-photon emission computed tomography-computed tomography (SPECT-CT) in examining such patients has not been evaluated. Here, we report the value of 99mTc-labeled RBC hybrid SPECT-CT over planar scintigraphy alone in a patient with BRBNS.